Rasagiline mesylate
Manus Aktteva Biopharma LLP, a global supplier of Rasagiline mesylate, 161735-79-1 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.
Chemical Name:
(R)-N-2-Propynyl-1-indanamine methanesulfonate, Rasagiline mesylate
Certificate:
GMP, Factory GMP, GMP - SFDA, cGMP, Product GMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico
Application:
For R&D Purpose
Email To:
Your Email:
Your Name:
Note:
Processing....
Synonym
(R)-N-2-Propynyl-1-indanamine methanesulfonate, Rasagiline mesylate
Specifications
Available on request
Packing
Export worthy packing
Material Safety Data Sheet
Available on request
| Product Name |
CAS No. |
|
| 2,3-Dihydro-1H-inden-1-amine hydrochloride |
70146-15-5 |
View | Inquire |
| (R)-(-)-Indanamine |
10277-74-4 |
View | Inquire |
| (R)-2,3-Dihydro-1H-inden-1-amine hydrochloride |
10305-73-4 |
View | Inquire |
| 1-Indanone |
83-33-0 |
View | Inquire |
| 1-Aminoindan |
34698-41-4 |
View | Inquire |
Description:
Rasagiline Mesylate, CAS NO 161735-79-1, is used for the treatment of Parkinson's disease. Rasagiline is an irreversible inhibitor of monoamine oxidase used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases. Rasagiline Mesylate should always be used according to your physician's instructions to get the most effective results. It is normally taken once daily, but your individual regiment will depend on your current health condition and the severity of your symptoms. Manus Aktteva Biopharma LLP, a global supplier of Rasagiline mesylate offers for your requirements with supportive technical package required for evaluation.
- Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
- Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
- Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
- Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
- Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.
Are you looking for Rasagiline mesylate with documentation like PMDA - JAPAN, DMF - CANADA, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, ICH, COPP, TDMF, Written Confirmation? Please
click here to send us sourcing request.
Rasagiline mesylate, 161735-79-1, USDMF, EDMF, CEP / COS, TGA - AUSTRALIA, DMF (OPEN PART), DMF (CLOSED PART), MHRA - UK, TDP, DMF - CTD, GMP, Factory GMP, GMP - SFDA, cGMP, Product GMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico, Price, Cost, Manufacturer, Exporter, Supplier, India, China, MSDS
Queries
Easy ways to get the answers you need.
+91 79 65123395
+91 79 26463395
